These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 32214362

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
    Peng S, Ferrall L, Gaillard S, Wang C, Chi WY, Huang CH, Roden RBS, Wu TC, Chang YN, Hung CF.
    mBio; 2021 Jan 19; 12(1):. PubMed ID: 33468698
    [Abstract] [Full Text] [Related]

  • 3. Antibody response for L1, E6 and E7 HPV 16 and HPV 18 antigens in Tunisian women with cervical cancer and controls.
    Achour M, Zeghal D, Kochbati L, Kahla S, Zouari F, Maalej M, Oueslati R.
    J Immunoassay Immunochem; 2008 Jan 19; 29(3):266-80. PubMed ID: 18569375
    [Abstract] [Full Text] [Related]

  • 4. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K, Kisseljov F, Sacharova O, Shaichaev G, Semjonova L, Pavlova L, Pawlita M.
    Int J Cancer; 2000 Feb 01; 85(3):313-8. PubMed ID: 10652419
    [Abstract] [Full Text] [Related]

  • 5. Antibody response for L1, E6, E7 HPV 16, and HPV 18 antigens in Tunisian women with cervical cancer.
    Achour M, Zeghal D, Kochbati L, Kahla S, Zouari F, Maâlej M, Oueslati R.
    J Immunoassay Immunochem; 2009 Feb 01; 30(1):82-96. PubMed ID: 19117204
    [Abstract] [Full Text] [Related]

  • 6. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y, Choi JW, Kim HJ, Eddouzi J, Kim SC, Ju W, Kim YH, Kim HJ.
    Cancer Med; 2018 Nov 01; 7(11):5655-5664. PubMed ID: 30353680
    [Abstract] [Full Text] [Related]

  • 7. A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer.
    Hasan Y, Furtado L, Tergas A, Lee N, Brooks R, McCall A, Golden D, Jolly S, Fleming G, Morrow M, Kraynyak K, Sylvester A, Arif F, Levin M, Schwartz D, Boyer J, Skolnik J, Esser M, Kumar R, Bagarazzi M, Weichselbaum R, Spiotto M.
    Int J Radiat Oncol Biol Phys; 2020 Jul 01; 107(3):487-498. PubMed ID: 32151670
    [Abstract] [Full Text] [Related]

  • 8. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
    Monroy-García A, Gómez-Lim MA, Weiss-Steider B, la Rosa GP, Hernández-Montes J, Pérez-Saldaña K, Tapia-Guerrero YS, Toledo-Guzmán ME, Santiago-Osorio E, Sanchez-Peña HI, Mora-García Mde L.
    Virol J; 2011 Feb 09; 8():59. PubMed ID: 21306638
    [Abstract] [Full Text] [Related]

  • 9. Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies.
    Hu R, Dong Z, Zhang K, Pan G, Li C, Cui H.
    Viruses; 2020 Mar 19; 12(3):. PubMed ID: 32204370
    [Abstract] [Full Text] [Related]

  • 10. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
    Reuschenbach M, Waterboer T, Wallin KL, Einenkel J, Dillner J, Hamsikova E, Eschenbach D, Zimmer H, Heilig B, Kopitz J, Pawlita M, Doeberitz Mv, Wentzensen N.
    Int J Cancer; 2008 Dec 01; 123(11):2626-31. PubMed ID: 18785210
    [Abstract] [Full Text] [Related]

  • 11. Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay.
    Menegaldo A, Schroeder L, Holzinger D, Tirelli G, Dal Cin E, Tofanelli M, Rigo S, Mantovani M, Stellin M, Del Mistro A, Dei Tos AP, Guerriero A, Niero M, Borsetto D, Da Mosto MC, Polesel J, Pawlita M, Waterboer T, Boscolo-Rizzo P.
    Laryngoscope; 2021 May 01; 131(5):1042-1048. PubMed ID: 33103777
    [Abstract] [Full Text] [Related]

  • 12. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.
    Nindl I, Benitez-Bribiesca L, Berumen J, Farmanara N, Fisher S, Gross G, Lopez-Carillo L, Müller M, Tommasino M, Vazquez-Curiel A.
    Arch Virol; 1994 May 01; 137(3-4):341-53. PubMed ID: 7524466
    [Abstract] [Full Text] [Related]

  • 13. Serological study in Tunisian cervical cancer patients.
    Achour M, Kochbati L, Zeghal D, Kahla S, Maalej M, Zouari F, Oueslati R.
    Pathol Biol (Paris); 2009 Jul 01; 57(5):415-9. PubMed ID: 18586408
    [Abstract] [Full Text] [Related]

  • 14. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
    Gambhira R, Gravitt PE, Bossis I, Stern PL, Viscidi RP, Roden RB.
    Cancer Res; 2006 Dec 01; 66(23):11120-4. PubMed ID: 17145854
    [Abstract] [Full Text] [Related]

  • 15. Analysis of antibody response to HPV 16 and HPV 18 antigens in Tunisian patients.
    Achour M, Kahla S, Zeghal D, Kochbati L, Mongi M, Zouari F, Oueslati R.
    Viral Immunol; 2009 Feb 01; 22(1):7-16. PubMed ID: 19210223
    [Abstract] [Full Text] [Related]

  • 16. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
    Hasan UA, Bates E, Takeshita F, Biliato A, Accardi R, Bouvard V, Mansour M, Vincent I, Gissmann L, Iftner T, Sideri M, Stubenrauch F, Tommasino M.
    J Immunol; 2007 Mar 01; 178(5):3186-97. PubMed ID: 17312167
    [Abstract] [Full Text] [Related]

  • 17. Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer.
    Anderson KS, Wong J, D'Souza G, Riemer AB, Lorch J, Haddad R, Pai SI, Longtine J, McClean M, LaBaer J, Kelsey KT, Posner M.
    Br J Cancer; 2011 Jun 07; 104(12):1896-905. PubMed ID: 21654689
    [Abstract] [Full Text] [Related]

  • 18. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Singini MG, Muchengeti M, Sitas F, Chen WC, Combes JD, Waterboer T, Clifford GM.
    Int J Cancer; 2024 Jul 15; 155(2):251-260. PubMed ID: 38577820
    [Abstract] [Full Text] [Related]

  • 19. Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis.
    Jabbar B, Rafique S, Salo-Ahen OMH, Ali A, Munir M, Idrees M, Mirza MU, Vanmeert M, Shah SZ, Jabbar I, Rana MA.
    Front Immunol; 2018 Jul 15; 9():3000. PubMed ID: 30619353
    [Abstract] [Full Text] [Related]

  • 20. Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
    Sun Y, Shah KV, Müller M, Muñoz N, Bosch XF, Viscidi RP.
    J Clin Microbiol; 1994 Sep 15; 32(9):2216-20. PubMed ID: 7529250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.